Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer

Journal of Clinical Oncology

Volumn 4, Issue 10, 1986, Pages 1443-1454

  Ihde, D C ^a   Deisseroth, A B ^a   Lichter, A S ^a   Bunn, P A ^b   Carney, D N ^b   Cohen, M H ^b   Veach, S R ^b   Makuch, R W ^b   Johnston Early, A ^b   Abrams, R A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG EFFICACY; DRUG THERAPY; ESOPHAGITIS; ESOPHAGUS; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; RADIOTHERAPY; RESPIRATORY SYSTEM; SURVIVAL; THERAPY;

EID: 0023028697     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1986.4.10.1443     Document Type: Article

References (0)